![]()
|
|
||||||||
(Received for publication, August 26, 1996, and in revised form, October 11, 1996)
From the Division of Molecular Biology and Biochemistry, School of
Biological Sciences, University of Missouri,
Kansas City, Missouri 64110
Once internalized, cell-associated heparan
sulfate proteoglycans are degraded to short glycosaminoglycans by the
action of endoglycosidases or heparanases. We have begun to address the question of how many heparanases are responsible for this process by
analyzing short heparan sulfate chains produced in vivo by Chinese hamster ovary (CHO) cell heparanases. Short heparan sulfate chains were purified from CHO cells and labeled at the reducing end
with [3H]NaBH4. Hydrolysis of the chains to
monosaccharides and analysis of the 3H-sugar alcohols
indicate that heparanase activities in CHO cells are
endo-
-glucuronidases. The modification state of the
heparanase-derived glycosaminoglycans was examined by treating the
[3H]heparan sulfate chains with nitrous acid or bacterial
heparin lyases, which cut the chain at specific sequences, and
analyzing the products by P2 gel filtration chromatography. Two
populations of short chains were identified that differ in the extent
of modification on the nonreducing side of the heparanase cleavage
site. One class of chains is unmodified for at least 9 residues from
the reducing end, while the other group has a modified domain within
3-7 residues from the heparanase cleavage site. Our results suggest a
model of heparanase action where the enzymes recognize differences in sulfate content between modified and unmodified regions and bind to
sites that encompass both domains. The enzymes then cleave the
glycosaminoglycan at junctions between the modified and unmodified sequences to produce the different populations of short heparan sulfate
chains.
This article has been cited by other articles:
![]() |
M. Fuller, A. Chau, R. C. Nowak, J. J. Hopwood, and P. J. Meikle A defect in exodegradative pathways provides insight into endodegradation of heparan and dermatan sulfates Glycobiology, April 1, 2006; 16(4): 318 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fuller, P. J. Meikle, and J. J. Hopwood Glycosaminoglycan degradation fragments in mucopolysaccharidosis I Glycobiology, May 1, 2004; 14(5): 443 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reiland, R. D. Sanderson, M. Waguespack, S. A. Barker, R. Long, D. D. Carson, and D. Marchetti Heparanase Degrades Syndecan-1 and Perlecan Heparan Sulfate: FUNCTIONAL IMPLICATIONS FOR TUMOR CELL INVASION J. Biol. Chem., February 27, 2004; 279(9): 8047 - 8055. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Podyma-Inoue, H. Yokote, K. Sakaguchi, M. Ikuta, and M. Yanagishita Characterization of Heparanase from a Rat Parathyroid Cell Line J. Biol. Chem., August 30, 2002; 277(36): 32459 - 32465. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bame Heparanases: endoglycosidases that degrade heparan sulfate proteoglycans Glycobiology, June 1, 2001; 11(6): 91R - 98R. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bame, I. Venkatesan, H. D. Stelling, and S. Tumova The spacing of S-domains on HS glycosaminoglycans determines whether the chain is a substrate for intracellular heparanases Glycobiology, July 1, 2000; 10(7): 715 - 726. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toyoshima and M. Nakajima Human Heparanase. PURIFICATION, CHARACTERIZATION, CLONING, AND EXPRESSION J. Biol. Chem., August 20, 1999; 274(34): 24153 - 24160. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Pikas, J.-p. Li, I. Vlodavsky, and U. Lindahl Substrate Specificity of Heparanases from Human Hepatoma and Platelets J. Biol. Chem., July 24, 1998; 273(30): 18770 - 18777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yamada, Y. Yamane, H. Tsuda, K. Yoshida, and K. Sugahara A Major Common Trisulfated Hexasaccharide Core Sequence, Hexuronic Acid(2-Sulfate)-Glucosamine(N-Sulfate)-Iduronic Acid-N-Acetylglucosamine-Glucuronic Acid-Glucosamine(N-Sulfate), Isolated from the Low Sulfated Irregular Region of Porcine Intestinal Heparin J. Biol. Chem., January 23, 1998; 273(4): 1863 - 1871. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Bai, K. J. Bame, H. Habuchi, K. Kimata, and J. D. Esko Turnover of Heparan Sulfate Depends on 2-O-Sulfation of Uronic Acids J. Biol. Chem., September 12, 1997; 272(37): 23172 - 23179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Bame, J. Danda, A. Hassall, and S. Tumova Abeta (1-40) Prevents Heparanase-catalyzed Degradation of Heparan Sulfate Glycosaminoglycans and Proteoglycans in Vitro. A ROLE FOR HEPARAN SULFATE PROTEOGLYCAN TURNOVER IN ALZHEIMER'S DISEASE J. Biol. Chem., July 4, 1997; 272(27): 17005 - 17011. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tumova and K. J. Bame The Interaction between Basic Fibroblast Growth Factor and Heparan Sulfate Can Prevent the in Vitro Degradation of the Glycosaminoglycan by Chinese Hamster Ovary Cell Heparanases J. Biol. Chem., April 4, 1997; 272(14): 9078 - 9085. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ding, M. Jonsson, K. Mani, S. Sandgren, M. Belting, and L.-A. Fransson N-Unsubstituted Glucosamine in Heparan Sulfate of Recycling Glypican-1 from Suramin-treated and Nitrite-deprived Endothelial Cells. MAPPING OF NITRIC OXIDE/NITRITE-SUSCEPTIBLE GLUCOSAMINE RESIDUES TO CLUSTERED SITES NEAR THE CORE PROTEIN J. Biol. Chem., February 2, 2001; 276(6): 3885 - 3894. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |